discontinued

GTX22815 Retinoid X Receptor beta [MOK13-17] antibody

See related secondary antibodies

Search for all "Retinoid X Receptor beta [MOK13-17]"

0.1 mg / €380.00

Quick Overview

Mouse anti Human, Mouse Retinoid X Receptor beta [MOK13-17] MOK13-17

GTX22815

Product Description for Retinoid X Receptor beta [MOK13-17]

Mouse anti Human, Mouse Retinoid X Receptor beta [MOK13-17] MOK13-17.
Presentation: Ascites
Product is tested for Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Western blot / Immunoblot.

Properties for Retinoid X Receptor beta [MOK13-17]

Product Category Primary Antibodies
Quantity 0.1 mg
Presentation Ascites
Reactivity Hu, Ms
Applications ICC/IF, IP, WB
Clonality Monoclonal
Clone MOK13-17
Host Mouse
Isotype IgG1
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer GeneTex Inc.

Datasheet Extract

Immunogen
Immunogen:
Recombinant full length protein (Human).
Application GSA, IF, IP, WB
Background Retinoid X receptors (RXRs) are members of the steroid/thyroid hormone receptor superfamily of nuclear receptor proteins which exert their effects by binding to specific DNA response elements, thus regulating gene expression in target cells. The RXR subfamily consists of at least three similar genes, RXR alpha, RXR beta and RXR gamma, all of which control transcription of target genes mediated by retinoids. RXR beta controls expression of many genes that respond to hormones and vitamins, including thyroid hormone, estrogen, retinoids and vitamin D. RXR beta controls a wide array of genes because of its ability to heterodimerize with other hormone receptors including the thyroid hormone receptor (THR), vitamin D receptor (VDR) and retinoic acid receptor (RAR).
Storage Upon receipt - Keep as concentrated solution. Aliquot and store at -20
Format
Purification:
Ascites
Buffer System:
PBS with 0.05% sodium azide
Purity:
Ascites
State:
Liquid-50ul
Ascites
Specificity
Specificity:
Cross-reacts with Human and Mouse. Not yet tested in other species.

Accessory Products

  • LinkedIn